Chemical Structure (F205834f 7a27 4968 9605 90a2c53ce7e9 01)
Losartan Potassium Tablet
Product Images NDC 72162-2507
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 72162-2507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (F205834f 7a27 4968 9605 90a2c53ce7e9 02)
This text provides information on a study comparing Atenolol and Losartan potassium in patients, showing an adjusted risk reduction of 13% with a significance level of p=0.021. It also includes a timeline of study months from 0 to 66.*
Figure 2 (F205834f 7a27 4968 9605 90a2c53ce7e9 03)
Figure 3 (F205834f 7a27 4968 9605 90a2c53ce7e9 04)
Figure 4 (F205834f 7a27 4968 9605 90a2c53ce7e9 05)
This description provides data on the effectiveness of Losartan Potassium in reducing the risk of an event in patients. The study shows that there was a 16.1% risk reduction with a statistical significance of p=0.022. Additionally, the text mentions that 9% of patients experienced the event. The comparison is made between Losartan Potassium and a placebo, with 36 patients in the Losartan group and 8 patients in the placebo group.*
Image (F205834f 7a27 4968 9605 90a2c53ce7e9 06)
Company Logo (F205834f 7a27 4968 9605 90a2c53ce7e9 07)
Label (Lbl721622507)
This is the package insert for Losartan Potassium tablets, with each tablet containing 50 mg of Losartan Potassium. The information includes details about dosage, storage conditions (20° to 25°C), and the manufacturer (Bryant Ranch Prepack, Inc., Unichem Laboratories Ltd.). It also provides instructions for pharmacists to dispense the tablets and advises to keep drugs out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
